NDA Partners General Manager, Eric Fish, announced today that David Wurtman, MD, MBA, an experienced business executive and product development expert, has joined the company as an Expert Consultant. Dr. Wurtman formerly served as Chief Executive Officer of Lyric Pharmaceuticals, an ICU therapeutic development company, and Chief Medical Officer of Lucid Diagnostics.
WASHINGTON (PRWEB) June 23, 2022
NDA Partners General Manager, Eric Fish, announced today that David Wurtman, MD, MBA, an experienced business executive and product development expert, has joined the company as an Expert Consultant. Dr. Wurtman joined the firm to support companies with corporate strategy, fundraising, mergers & acquisitions, business development & licensing, product development, market research, product positioning, and, clinical-regulatory strategy and development. He has particular expertise in assisting emerging and start-up product and platform companies.
Dr. Wurtman has served as CEO of Lyric Pharmaceuticals, an ICU therapeutic development company which he founded, built and successfully funded, and as CMO of Lucid Diagnostics, a medical device company which went public via an Initial Public Offering (IPO) in 2021. He has consulted to more than 25 biopharmaceutical, technology platform, medical device, diagnostic, and healthcare IT companies and led or advised on ~25 transactions and raised over $70MM from Venture Capital, Private Equity, Family Office, and the US Government. He has deep development expertise across drugs, biologics, and diagnostic devices and has led successful FDA interactions, including obtaining FDA Breakthrough Designation.
Dr. Wurtman is a Board Certified Internal Medicine physician and in addition to his roles with Lyric and Lucid, he also held roles in Corporate, Business and Product Development at Genzyme, Protein Design Labs, Eos Biotechnology, Kineta, and Ansun Biopharma.
According to Dr. Alberto Gutierrez, Manager of NDA Partners' diagnostic device practice, "Dr. Wurtman brings valuable experience in business development, product development, and helping to build and lead development teams for early-stage drug, biologic, and diagnostic device companies. We are pleased to welcome him to NDA Partners."
Dr. David Wurtman earned his medical degree from Harvard Medical School and MBA from MIT Sloan School of Management. He completed his residency in internal medicine at Mount Auburn, a Harvard Teaching Hospital, and fellowships with Ben Gurion University of the Negev, Israel and the Department of Hormone Research, Weizmann Institute, Israel.
About NDA Partners
NDA Partners, a ProPharma Group company, is a life sciences management consulting and contract development organization focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Expert Consultants in NDA Partners include three former FDA Center Directors; the former Chief Executive Officer and Chief Science Officer at the United States Pharmacopeial Convention (USP); an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, product development program design and management, expert consulting, functional teams, project-based solutions, and clinical trial design and management.
Eric Fish, General Manager
For the original version on PRWeb visit: https://www.prweb.com/releases/former_lucid_diagnostics_chief_medical_officer_david_wurtman_joins_nda_partners_as_expert_consultant/prweb18751064.htm
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.
All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.
Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.
Rate collection and criteria: Click here for more information on rate collection and criteria.